全文获取类型
收费全文 | 2501篇 |
免费 | 175篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 66篇 |
妇产科学 | 25篇 |
基础医学 | 313篇 |
口腔科学 | 20篇 |
临床医学 | 233篇 |
内科学 | 703篇 |
皮肤病学 | 34篇 |
神经病学 | 215篇 |
特种医学 | 99篇 |
外科学 | 438篇 |
综合类 | 13篇 |
预防医学 | 186篇 |
眼科学 | 16篇 |
药学 | 154篇 |
中国医学 | 7篇 |
肿瘤学 | 149篇 |
出版年
2023年 | 24篇 |
2022年 | 30篇 |
2021年 | 48篇 |
2020年 | 52篇 |
2019年 | 69篇 |
2018年 | 84篇 |
2017年 | 62篇 |
2016年 | 51篇 |
2015年 | 69篇 |
2014年 | 80篇 |
2013年 | 118篇 |
2012年 | 167篇 |
2011年 | 171篇 |
2010年 | 102篇 |
2009年 | 104篇 |
2008年 | 166篇 |
2007年 | 141篇 |
2006年 | 175篇 |
2005年 | 172篇 |
2004年 | 136篇 |
2003年 | 125篇 |
2002年 | 112篇 |
2001年 | 45篇 |
2000年 | 33篇 |
1999年 | 32篇 |
1998年 | 27篇 |
1997年 | 16篇 |
1996年 | 8篇 |
1995年 | 16篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 34篇 |
1991年 | 23篇 |
1990年 | 25篇 |
1989年 | 16篇 |
1988年 | 22篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 13篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1977年 | 5篇 |
1975年 | 3篇 |
1974年 | 6篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1970年 | 3篇 |
排序方式: 共有2687条查询结果,搜索用时 15 毫秒
51.
Martínez-Borra J López-Larrea C González S Fuentes D Dieguez A Deschamps EM Pérez-Pariente JM López-Vázquez A de Francisco R Rodrigo L 《The American journal of gastroenterology》2002,97(9):2350-2356
OBJECTIVES: Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor-alpha (anti-TNF-alpha), has been effective in the treatment of patients with active Crohn's disease and with fistulas. We investigated the effect of infliximab on circulating cytokines and acute phase proteins in patients with fistulas to determine the clinical response to anti-TNF-alpha. METHODS: A total of 36 patients with fistulizing Crohn's disease were selected for study. Serum from patients was drawn before the infusion on day 0 and at wk 2, 4, 6, 8, and 10 after completion of treatment. Circulating concentrations of TNF-alpha, interleukin-1beta (IL-1beta), and IL-6 were measured by ELISA. The functional activity of circulating TNF-alpha was assessed by the WEHI 164 TNF-alpha bioassay. Acute phase proteins were also determined. RESULTS: Elevated TNF-alpha, IL-1beta, IL-6, and acute phase proteins were observed in patients with Crohn's disease. Of the patients with fistulas, 22 (61.1%) responded to treatment. Before receiving infliximab, higher levels of serum TNF-alpha were found in patients who did not respond to infliximab compared with those who did (median interquartile range 26, 0-245 pg/ml; n = 14 vs 0, 0-22 pg/ml, n = 22). Patients showed no change in circulating levels of TNF-alpha during the course of the study. CONCLUSIONS: This treatment produces a clinical improvement in about two-thirds of CD patients with fistulas. The circulating levels of TNF-alpha are associated with the response to infliximab and could help to identify patients who would benefit from anti-TNF-alpha treatment. 相似文献
52.
53.
Pierre Frange David Boutolleau Marianne Leruez-Ville Fabien Touzot Guilhem Cros Sebastien Heritier Despina Moshous Benedicte Neven Alain Fischer Stephane Blanche 《Journal of clinical microbiology》2013,51(12):4266-4269
We describe a case of antiviral-resistant cytomegalovirus meningoencephalitis occurring after hematopoietic stem cell transplantation. Antiviral-resistant cytomegalovirus was identified in blood 16 months earlier. However, wild-type cytomegalovirus was evidenced in blood when the meningoencephalitis was diagnosed. Treatment of meningoencephalitis should be adapted to all previously identified resistance mutations in any compartment. 相似文献
54.
Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients 总被引:24,自引:0,他引:24
Bader H Garrigue S Lafitte S Reuter S Jaïs P Haïssaguerre M Bonnet J Clementy J Roudaut R 《Journal of the American College of Cardiology》2004,43(2):248-256
OBJECTIVES: We sought to assess the electromechanical parameters, using tissue Doppler echocardiography, as potential independent predictors of heart failure (HF) worsening. BACKGROUND: Ventricular conduction disorders worsen the prognosis for HF patients. However, the relationships between the QRS width and morphology, hemodynamic parameters, and presence and magnitude of intra-left ventricular (LV) and inter-ventricular (V) asynchrony have not been well clarified. METHOD: A total of 104 patients with an LV ejection fraction (EF) =45% and stabilized HF, without myocardial infarction (MI), underwent echocardiography coupled with tissue Doppler imaging and were followed for one year. The protocol analyzed the incidence of worsening HF (hospitalization for cardiac decompensation). Inter-V and regional electromechanical delays for the anterior, septal, inferior, and lateral LV walls were correlated with the QRS morphology and duration. The intra-LV and inter-V asynchrony values of these patients were compared with those of healthy subjects matched by gender and age criteria to determine the respective normal ranges. RESULTS: The presence of intra-LV (but not inter-V) asynchrony was identified as an independent predictor of severe cardiac events (hazard ratio 3.39, p < 0.0001), independent of the LVEF and QRS width. Of patients with a QRS width <120 ms (55%; n = 57), 56% presented with major intra-LV asynchrony and 12% with inter-V asynchrony. Intra-LV asynchrony was observed in 84% of left bundle branch block patients, but also in 83% of right bundle branch block patients (p = NS). There was a poor correlation between the QRS width and intra-LV or inter-V asynchrony (r = 0.36, p = NS and r = 0.43, p = 0.05, respectively). CONCLUSIONS: In HF patients without MI, patients with intra-LV asynchrony are those with a significantly higher risk of cardiac events, independent of the QRS width and LVEF. Accordingly, such patients should be more actively identified for early intensive treatment and survey. 相似文献
55.
Walter J Paulus Carsten Tsch?pe John E Sanderson Cesare Rusconi Frank A Flachskampf Frank E Rademakers Paolo Marino Otto A Smiseth Gilles De Keulenaer Adelino F Leite-Moreira Attila Borbély István Edes Martin Louis Handoko Stephane Heymans Natalia Pezzali Burkert Pieske Kenneth Dickstein Alan G Fraser Dirk L Brutsaert 《European heart journal》2007,28(20):2539-2550
Diastolic heart failure (DHF) currently accounts for more than 50% of all heart failure patients. DHF is also referred to as heart failure with normal left ventricular (LV) ejection fraction (HFNEF) to indicate that HFNEF could be a precursor of heart failure with reduced LVEF. Because of improved cardiac imaging and because of widespread clinical use of plasma levels of natriuretic peptides, diagnostic criteria for HFNEF needed to be updated. The diagnosis of HFNEF requires the following conditions to be satisfied: (i) signs or symptoms of heart failure; (ii) normal or mildly abnormal systolic LV function; (iii) evidence of diastolic LV dysfunction. Normal or mildly abnormal systolic LV function implies both an LVEF > 50% and an LV end-diastolic volume index (LVEDVI) <97 mL/m(2). Diagnostic evidence of diastolic LV dysfunction can be obtained invasively (LV end-diastolic pressure >16 mmHg or mean pulmonary capillary wedge pressure >12 mmHg) or non-invasively by tissue Doppler (TD) (E/E' > 15). If TD yields an E/E' ratio suggestive of diastolic LV dysfunction (15 > E/E' > 8), additional non-invasive investigations are required for diagnostic evidence of diastolic LV dysfunction. These can consist of blood flow Doppler of mitral valve or pulmonary veins, echo measures of LV mass index or left atrial volume index, electrocardiographic evidence of atrial fibrillation, or plasma levels of natriuretic peptides. If plasma levels of natriuretic peptides are elevated, diagnostic evidence of diastolic LV dysfunction also requires additional non-invasive investigations such as TD, blood flow Doppler of mitral valve or pulmonary veins, echo measures of LV mass index or left atrial volume index, or electrocardiographic evidence of atrial fibrillation. A similar strategy with focus on a high negative predictive value of successive investigations is proposed for the exclusion of HFNEF in patients with breathlessness and no signs of congestion. The updated strategies for the diagnosis and exclusion of HFNEF are useful not only for individual patient management but also for patient recruitment in future clinical trials exploring therapies for HFNEF. 相似文献
56.
Stephane Noble MD Marco Roffi MD 《Catheterization and cardiovascular interventions》2014,84(6):897-899
In rare cases, retrograde aortic valve crossing during transcatheter aortic valve implantation may be challenging despite improvements in delivery catheter profile, size, and steerability compared with the first generation devices. Herein, we report a case of challenging transfemoral Medtronic CoreValve placement that was possible, thanks to the buddy balloon technique, using a peripheral 6‐F compatible balloon. © 2013 Wiley Periodicals, Inc. 相似文献
57.
Alexandra Spiegel Catherine Paillard Stephane Ducassou Yves Perel Dominique Plantaz Marion Strullu Alice Eischen Patrick Lutz Laurence Lamant Marie‐Cécile Le Deley Laurence Brugières 《British journal of haematology》2014,165(4):545-551
This study aimed to describe the clinical features and outcome of anaplastic large cell lymphoma (ALCL) with leukaemic presentation in children. Among 267 patients included in the French paediatric ALCL database between 1989 and 2012, nine (3%) were described as having cytologically detectable circulating tumour cells. Clinical features combined fever (8/9), nodal and extra‐nodal disease (9/9), including hepato‐splenic (9/9) and lung involvement (7/9). The level of hyperleucocytosis ranged from 30 to 120 × 109/l, with 12–90% of tumour cells. Diagnosis relied on a lymph node biopsy, with a positive ALK+ antibody immunostain in all nine cases, a T‐cell immunophenotype in 7/9 cases and CD3 positivity in 5/9 cases. A small cell component was present in 6/9 cases. Only four patients achieved a complete remission with first‐line therapy and 3/4 relapsed. Four patients are alive with a median follow‐up of 31 months, two of them after allogeneic haematopoietic stem cell transplantation (HSCT), and five patients died, two of them of disease. In conclusion, ALCL with leukaemic presentation is very unusual and should be considered as high‐risk lymphoma requiring new therapeutic strategies. The respective role of new agents and allogeneic HSCT in first complete remission still has to be assessed. 相似文献
58.
59.
Brunner R Aissaoui H Boss C Bozdech Z Brun R Corminboeuf O Delahaye S Fischli C Heidmann B Kaiser M Kamber J Meyer S Papastogiannidis P Siegrist R Voss T Welford R Wittlin S Binkert C 《The Journal of infectious diseases》2012,206(5):735-743
The increasing spread of drug-resistant malaria strains underscores the need for new antimalarial agents with novel modes of action (MOAs). Here, we describe a compound representative of a new class of antimalarials. This molecule, ACT-213615, potently inhibits in vitro erythrocytic growth of all tested Plasmodium falciparum strains, irrespective of their drug resistance properties, with half-maximal inhibitory concentration (IC(50)) values in the low single-digit nanomolar range. Like the clinically used artemisinins, the compound equally and very rapidly affects all 3 asexual erythrocytic parasite stages. In contrast, microarray studies suggest that the MOA of ACT-213615 is different from that of the artemisinins and other known antimalarials. ACT-213615 is orally bioavailable in mice, exhibits activity in the murine Plasmodium berghei model and efficacy comparable to that of the reference drug chloroquine in the recently established P. falciparum SCID mouse model. ACT-213615 represents a new class of potent antimalarials that merits further investigation for its clinical potential. 相似文献
60.
ME Boel MJ Rijken M Pimanpanarak NL Keereecharoen S Proux F Nosten R McGready 《The American journal of tropical medicine and hygiene》2012,87(3):447-449
Abstract. In a few small studies an association between blood group O and placental malaria has been described. The relationship between blood group and malaria in pregnancy (Plasmodium vivax and Plasmodium falciparum) was analyzed in 1,468 women from three longitudinal cohort studies in which weekly malaria screening was done systematically during pregnancy. One-third of women (447 of 1,468) had at least one malaria infection in pregnancy. The ABO blood group phenotype was not associated with the species of infection, frequency of malaria attacks, symptoms of malaria, hematocrit, or parasitemia during pregnancy. 相似文献